EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs

The epithelial cell adhesion molecule (EpCAM), or CD326, was one of the first cancer associated biomarkers to be discovered. In the last forty years, this biomarker has been investigated for use in personalized cancer therapy, with the first monoclonal antibody, edrecolomab, being trialled in humans...

Descripción completa

Detalles Bibliográficos
Autores principales: Macdonald, Joanna, Henri, Justin, Roy, Kislay, Hays, Emma, Bauer, Michelle, Veedu, Rakesh Naduvile, Pouliot, Normand, Shigdar, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789369/
https://www.ncbi.nlm.nih.gov/pubmed/29329202
http://dx.doi.org/10.3390/cancers10010019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789369/
https://www.ncbi.nlm.nih.gov/pubmed/29329202
http://dx.doi.org/10.3390/cancers10010019

Ejemplares similares